Pfizer's vaccine: Children under 5 years of age..!?
Pfizer's vaccine: Children under 5 years of age..!?
A Pfizer-BioNTech vaccine was approved in june to protect children under the age of 5 from the coronavirus, just as the vaccine protects the elderly. Data suggest that it builds immunity among children under 5 years of age. New data from the companies showed the vaccine was 73.2% effective at preventing COVID-19 among children aged 6 months to 4 years. But experts say the results are preliminary because they were conducted on a small number of children. According to these data, 13 children tested positive for Covid-19 at least seven days after receiving the third dose of the Pfizer-BioNTech COVID-19 vaccine, compared with 21 cases among those who received a placebo.
A Pfizer-BioNTech vaccine was approved in june to protect children under the age of 5 from the coronavirus, just as the vaccine protects the elderly. Data suggest that it builds immunity among children under 5 years of age. New data from the companies showed the vaccine was 73.2% effective at preventing COVID-19 among children aged 6 months to 4 years. But experts say the results are preliminary because they were conducted on a small number of children. According to these data, 13 children tested positive for Covid-19 at least seven days after receiving the third dose of the Pfizer-BioNTech COVID-19 vaccine, compared with 21 cases among those who received a placebo.
The Pfizer-BioNTech vaccine was approved in june for children under 5 years of age, and a preliminary analysis based on 10 symptomatic COVID-19 cases in a study based on data showing that the coronavirus vaccine produces the same immunity as adults suggests a vaccine efficacy of 80.3%. But experts cautioned that the data is preliminary due to the small number of symptomatic cases.